Diabetes treatment is constantly progressing, with new therapeutic options appearing to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the https://inesqykd670629.get-blogging.com/39536626/emerging-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment